Volume 9 Issue 4, October 2015

Lohmann & Rauscher, a leading international provider of high-quality medical devices and hygiene products for hospitals, medical practices and consumers for over 160 years, is looking to identify partners to drive innovation in advanced wound care over the next decade.

BTG combines medicines, device technology and new techniques to deliver more targeted treatments, and is leading the way in bringing these innovative interventional medicine therapies to market.

Three collaborative platforms—a Center for Innovation (COI), a tripartite industry-academia group (DUCR, TLO and UTEC) and the Translational Research Initiative (TRI)—showcase the University of Tokyo’s commitment to the development and commercialization of new healthcare technologies. To download the full article, please sign in.

Next-generation sequencing platforms are building market share not only in the research setting but also increasingly in population research and clinical applications.

NuGEN Technologies provides scientists and clinicians with innovative and reliable sample-preparation technologies for targeted genomic analysis and diagnostics.

Utilizing cloud-based genome informatics to inform next-generation sequencing diagnosis and treatment.

Utilizing cloud-based genome informatics to inform next-generation sequencing diagnosis and treatment.

Biocartis' molecular diagnostics make precision medicine simple.

Pacific Edge has expanded the international market for two new molecular tests that provide better detection and management of urothelial cancer. To download the full article, please sign in.

Global recognition and advances in precision medicine have led to new approaches in cancer treatments and a consequent increase in dealmaking.

Histide’s Cell Recoding Peptides provide a powerful tool as therapeutic agents for tissue regeneration.

A GMP CHO-K1 cell line kit for drug developers and service providers

stat-MD™ Global Health Management,Information, and Surveillance System